Boston (1)

Histiocytic Sarcoma (HS) (1)

Histiocytoses Erdheim-chester Disease (1)

Langerhans Cell Histiocytosis (LCH) (1)

Active, not recruiting (1)

phase 2 (1)

Dana-Farber Cancer Institute (1)

Celgene (1)

lenalidomide (1)

drug (1)

Other (1)

Interventional (1)

histiocytic sarcoma (hs)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Aug 26, 2022